Carrigan Rice

Ms. Carrigan Rice

Georgetown University, Washington D.C., USA
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Leah WilsonLeah Wilson
Leah Wilson
CRCarrigan Rice
Carrigan Rice
STSandra Thompson
Sandra Thompson
A rise in aging populations globally calls attention to factors that influence the well-being and health of older adults, including social participation. In Australia, rural older adults face cultural, social, and physical challenges that place them at risk for isolation. Thus, research surrounding social participation and healthy aging is increasingly relevant, especially in rural areas. This qualitative study in a remote town in Western Australia explores barriers and facilitators to older adults’ social participation. To investigate multiple perspectives, 23 adults aged 50+ and 19 organizations from a rural town were interviewed. A stakeholder reference group was engaged to refine the research design and validate the findings. Feedback from early interviews was used to refine the data collection process, thus enhancing the validity of the findings. Thematic analysis showed that health and mobility issues, inadequate infrastructure, poor sustainability, and cultural tensions commonly impacted social participation. Themes of rural town culture, cultural power dynamics, and rural stoicism were identified as cultural aspects that inhibited participation. Based on results of this study and the supporting literature, recommendations for inclusive activities include supporting community-designed programs, utilizing culturally sensitive language and personnel, expanding services using existing community resources, and diversifying older adults’ roles in existing groups.

15 July 2024 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
GCGrace Collins
Grace Collins
Hillary Stires AndrewsHillary Stires Andrews
Hillary Stires Andrews
BMBrittany McKelvey
Brittany McKelvey
CRCarrigan Rice
Carrigan Rice
JAJeff D. Allen
Jeff D. Allen
MSMark Stewart
Mark Stewart
Clinical trials supporting oncology drug approvals frequently underrepresent diverse racial and ethnic populations. Recent policies have focused on ensuring premarket clinical trials are more inclusive and representative of racial and ethnic diversity in the general U.S. population or intended patient population; however, recent U.S. Food and Drug Administration (FDA) guidance on postmarketing approaches to collecting data in underrepresented populations demonstrates that, in certain circumstances, postmarketing requirements and/or commitments (PMR/Cs) may be issued to conduct more representative studies if there are remaining questions about safety or efficacy. This analysis demonstrates that prior to 2020, no drugs had PMR/Cs to further characterize use in a more representative population, and in the last 3 years, more than half of novel oncology approvals have had such a PMR/C (21/40, 53%). In addition, this analysis helps to identify characteristics, such as single-arm pivotal trial design, U.S. enrollment, and results of safety subgroup analyses based on race and ethnicity, that may contribute to decisions to issue a PMR/C to conduct a study that is more representative of the racial and ethnic diversity of the U.S. or intended patient population. These results can inform efforts to improve premarket clinical trials to ensure they are representative and able to characterize use in any patient who may need the drug.

6 September 2023 in NAM Perspectives
Verified
Journal Article
Closed access
AGAmy Geller
Amy Geller
ABAlina Baciu
Alina Baciu
MAMaggie Anderson
Maggie Anderson
MAMostafa Abu-Hijlih
Mostafa Abu-Hijlih
UBUniversity of Maryland Baltimore
University of Maryland Baltimore
NANadia Altaher
Nadia Altaher
This discussion paper provides an overview of the Ninth Annual DC Public Health Case Challenge (1), a student competition held in 2022 by the National Academy of Medicine (NAM) […]